HealthBeacon, a medication adherence technology company, announced a partnership with a patient support provider, Bionical Solutions, on 10 June. Together, these companies aim to provide a truly digitally connected patient support programme (PSP) in the UK.

Partnerships such as this are a small indication of the clear development of a digital ecosystem within the healthcare space. Digital technology has been increasingly enabling a patient-centric model, which pharma companies need to adopt in order to remain relevant and deliver better health outcomes.

Medication adherence technology

HealthBeacon has developed the world’s first smart sharps bin for tracking patient adherence to chronic injectable medication. Launched in 13 markets, the smart bin has helped patients with chronic diseases adhere to their medication schedule, with 20–30% higher adherence within the first year. The burden of chronic diseases is rapidly increasing worldwide, and adherence to long-term therapies for these diseases is about 50% in developed countries on average.

Thus, smart digital technology from HealthBeacon has the potential to significantly lift some of the burdens caused by poor adherence. Combined with the targeted outreach PSP and a digitally connected platform from Bionical Solutions, HealthBeacon’s technology will not only become more widely accessible, but also offer a more personalised approach to patient treatment.

Other programmes or mobile apps, such as those focused on simple adherence reminders, have experienced difficulties in the past regarding effectiveness over longer periods. As such, the market is now undergoing a shift from simple reminder services toward richer, more personalised, patient support programmes.

The use of digital technologies in pharma continues to accelerate across many channels. Notably, there is an increasing number of smartphone apps that offer potential benefits to patients by improving treatment outcomes. Digital support tools are also increasingly being developed beyond a single channel, and are moving in the direction of connectedness. Digitally connected PSPs are a natural consequence of the digital revolution and will facilitate the patient-centric approach that pharma is aiming to adopt. Advances in connected devices, sensors, and predictive analytics will completely change the existing PSP models and eventually lead to truly personalised care for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.